|Joshua D. Hamermesh|
Vice President, Business and Corporate Development
Joshua Hamermesh is vice president, business and corporate development. He is responsible for the company's corporate strategy and business development initiatives. Prior to joining Infinity, Mr. Hamermesh held the position of senior vice president, strategy and corporate development at Pervasis Therapeutics, Inc. where he led strategic partnering initiatives for the company's product development portfolio. Prior to that, he served as vice president, commercial and business development at Molecular Insight Pharmaceuticals, Inc. where he completed numerous in-licensing transactions and supported the company's initial public offering. Mr. Hamermesh began his biotechnology career at Genzyme Corporation, where he served as chief operating officer of MG Biotherapeutics, a joint venture with Medtronic, Inc., after holding positions of increasing responsibility in the marketing and business development groups. He also served as a business strategy consultant to the industry at the Monitor Company.
Mr. Hamermesh received his M.B.A. from Harvard Business School and his B.A. in Economics from Amherst College.